# A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib

> **NCT04253223** · PHASE1 · TERMINATED · sponsor: **Duke University** · enrollment: 1 (actual)

## Conditions studied

- Hyperglycemia Drug Induced

## Interventions

- **BIOLOGICAL:** REMD-477

## Key facts

- **NCT ID:** NCT04253223
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-07
- **Primary completion:** 2021-05-05
- **Final completion:** 2021-05-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04253223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04253223, "A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04253223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*